OTLK
Outlook Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.67
+3.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2.05x
- P/S forward
- 6.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -15.70x
- Price / sales
- -140.25x
- Price / cash flow
- -2.86x
Enterprise value
- Enterprise value
- $170.3M
- EV / sales
- -146.43x
- EV / EBITDA
- -2.73x
- EV / EBIT
- -3.06x
- Market cap
- $163.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026